Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - May 22, 2018 Category: Drugs & Pharmacology Source Type: news
Huge surge in kids poisoned by ADHD pills since 2000
Between 2000 and 2014, around 10,000 American children under 19 were hospitalized, and three died after taking methylphenidate or amphetamine, a new study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news
Unnecessary And Accidental Use Of ADHD Drugs Increases Over 60%, Study Suggests
(CNN) — Exposure to common medications used to treat attention deficit hyperactivity disorder has increased by more than 60% in US children and adolescents, according to a new study.
The study, published Monday in the journal Pediatrics, looked at all calls to US poison control centers for unintentional or intentional exposure to ADHD medications between 2000 and 2014 among children and adolescents. The researchers found that the number of calls increased from 7,018 in 2000 to 11,486 in 2014 — a 64% increase.
According to the study’s authors, “exposure” refers to the unnecessary ingestion, inh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health ADHD Local TV Source Type: news
What Causes Flushing?
Discussion
Flushing is usually thought of as a benign condition such as blushing, but can be quite irritating if it is frequent or persistent (i.e. menopausal hot flashes) or even pathologic (i.e. malignancy). “Flushing is a subjective and sensation of warmth that is accompanied by reddening of the skin anywhere on the body but favors the face, neck, and upper torso…. Flushing can be broadly divided into episodic or persistent. Episodic flashing is mediated by the release of endogenous vasoactive mediators or medications, while persistent flushing result in a fixed facial erythema with telangiectasias and cyano...
Source: PediatricEducation.org - April 30, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
April 2018 RxNorm Release Available for Download
The RxNorm April 2018 Release is now available for download. A new Qualitative Distinction (QD) modifier “BX Rating” is included to distinguish generic methylphenidate products not therapeutically equivalent to the brand-name drug Concerta. (Source: UMLS News)
Source: UMLS News - April 13, 2018 Category: Databases & Libraries Source Type: news
Study points to potential misuse/abuse of ADHD drugs
(Wiley) A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news
Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 14, 2018 Category: Drugs & Pharmacology Source Type: news
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
BRIDGEWATER, N.J., Feb. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP (CII) in 18, 27, 36, and 54 mg strengths.
Amneal's methylphenidate is an AB-rat... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, methylphenidate, Concerta (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2018 Category: Pharmaceuticals Source Type: news
Cotempla XR ODT (Methylphenidate Extended-Release Orally Disintegrating Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2018 Category: Drugs & Pharmacology Source Type: news
Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension (New - Currently in Shortage
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news
Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 22, 2018 Category: Drugs & Pharmacology Source Type: news
Ritalin During Pregnancy May Raise Risk of Heart Defect in Baby
A new study found a small increased risk of having a baby with a heart defect if Ritalin/Concerta (methylphenidate) was taken by the mother-to-be. (Source: WebMD Health)
Source: WebMD Health - December 13, 2017 Category: Consumer Health News Source Type: news
ADHD drug use in pregnancy increases risk of heart defects, study finds
The attention-deficit hyperactivity disorder drug methylphenidate is associated with an increased risk of heart defects in infants whose mothers take the medication during pregnancy, according to a study published Wednesday in the journal JAMA Psychiatry. (Source: CNN.com - Health)
Source: CNN.com - Health - December 13, 2017 Category: Consumer Health News Source Type: news
ADHD Meds During Pregnancy Appear To Have Low Risk Of Birth Defects
Most ADHD medications appear to have no increased risk for birth defects except a very small increased risk for heart defects with methylphenidate use in the first trimester. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news
Extended-Release Methylphenidate Oral Tablets Extended-Release Methylphenidate Oral Tablets
A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
